These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3063505)

  • 1. Effects of acebutolol on the serum lipid profile.
    Clucas A; Miller N
    Drugs; 1988; 36 Suppl 2():41-50. PubMed ID: 3063505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta blockers on blood lipid profile.
    Lehtonen A
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
    Lehtonen A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN; Brownlee WC; Large DM
    Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids.
    van Brummelen P
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S51-5. PubMed ID: 6188920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind trial of the long-term effects of acebutolol and propranolol on serum lipoproteins in patients with stable angina pectoris.
    Miller NE; Nanjee MN; Rajput-Williams J; Coltart DJ
    Am Heart J; 1987 Oct; 114(4 Pt 2):1007-10. PubMed ID: 3310569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pindolol on serum lipoproteins in patients with coronary heart disease.
    Karmakoski J; Viikari J; Rönnemaa T
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):189-91. PubMed ID: 6862723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised two way crossover comparison of the effects of six weeks propranolol and acebutolol therapy on plasma lipid profiles in patients with hypertension or ischaemic heart disease.
    Tyagi S; Bhargava M; Bhattacharya J; Khalilullah M
    Indian Heart J; 1990; 42(2):117-9. PubMed ID: 2081608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre study of the efficacy and tolerance of acebutolol versus atenolol in the long term treatment of mild arterial hypertension.
    De Backer G
    Drugs; 1988; 36 Suppl 2():51-6. PubMed ID: 3063506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acebutolol effects on lipid profile.
    Schnaper HW
    Am J Cardiol; 1990 Sep; 66(9):49C-54C. PubMed ID: 2220651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mepindolol on serum lipids.
    Martignoni A; Perani G; Finardi G; Mastropasqua E; Fogari R
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):543-5. PubMed ID: 7174157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intrinsic sympathetic activity of beta-blockers on SA and AV nodes in man.
    Leclercq JF; Rosengarten MD; Kural S; Attuel P; Coumel P
    Eur J Cardiol; 1981; 12(6):367-75. PubMed ID: 6113145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients.
    Birnbaum J; DiBianco R; Becker KL; Muesing R; Costello RB; Singh SN; Gottdiener JS; Fletcher RD
    Clin Pharmacol Ther; 1983 Mar; 33(3):294-300. PubMed ID: 6337762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockade with intrinsic sympathetic activity modifies favorably exercise-induced changes in plasma lipoproteins.
    Van Nguyen P; Cleroux J; Peterson M; Leenen FH
    J Appl Physiol (1985); 1990 Aug; 69(2):485-9. PubMed ID: 1977731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions.
    Northcote RJ; Ballantyne D
    Clin Sci (Lond); 1987 May; 72(5):549-56. PubMed ID: 3581681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
    Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of intrinsic sympathomimetic activity for beta blockers.
    Jaillon P
    Am J Cardiol; 1990 Sep; 66(9):21C-23C. PubMed ID: 1977302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
    Metelitsa VI; Duda SG; Ostrovskaia TP; Malysheva NV; Lerman OV; Shastun RS; Manoshkina EM; Piotrovskiĭ VK; Rumiantsev DO; Belolipetskaia VG
    Kardiologiia; 1993; 33(4):32-8. PubMed ID: 7933789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.